Teratogenic Evaluation of 80% Ethanol Extract of Embelia schimperi Vatke Fruits on Rat Embryo and Fetuses

listen audio

Study Justification:
– The study aimed to evaluate the teratogenic effect of the hydroalcoholic extract of Embelia schimperi Vatke fruits on rat embryos and fetuses.
– This is important because E. schimperi is commonly consumed as an anthelminthic plant in Ethiopia, but there is limited data on its safety and toxicity.
– The study is particularly relevant because many Ethiopian mothers consume herbal medication during pregnancy, and it is important to understand the potential teratogenic effects of these plants.
Study Highlights:
– The study found that the administration of the 80% hydroalcoholic extract of E. schimperi fruit did not have a significant toxic effect on embryonic and fetal developmental indices in rats.
– However, histopathological evaluation of the placentas from the treatment groups showed inflammatory reactions and calcifications compared to the control groups.
– These findings suggest that while the extract may not have a direct teratogenic effect on the embryos and fetuses, it may affect the structural integrity of the placenta.
Study Recommendations:
– Further research is needed to understand the mechanism behind the inflammatory reactions and calcifications observed in the placenta.
– Additional studies should be conducted to evaluate the long-term effects of E. schimperi extract on offspring development and health.
– It is recommended to conduct clinical trials to assess the safety of E. schimperi extract in pregnant women before it is widely used as a herbal medication during pregnancy.
Key Role Players:
– Researchers and scientists specializing in teratology and reproductive toxicology.
– Obstetricians and gynecologists who can provide insights into the potential impact of E. schimperi extract on human pregnancy.
– Pharmacologists and toxicologists who can contribute to the understanding of the safety and toxicity of the extract.
– Ethnobotanists who can provide information on the traditional use of E. schimperi and its potential risks during pregnancy.
– Policy makers and regulatory authorities who can use the study findings to inform guidelines and regulations regarding the use of herbal medications during pregnancy.
Cost Items for Planning Recommendations:
– Research funding for conducting further studies, including clinical trials and long-term follow-up studies.
– Laboratory equipment and supplies for histopathological analysis and other necessary tests.
– Animal care and housing facilities for conducting animal experiments.
– Salaries and stipends for researchers, scientists, and other personnel involved in the study.
– Data management and analysis software.
– Publication and dissemination costs for sharing the study findings with the scientific community and policy makers.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong, but there are some areas for improvement. The study design is appropriate, with a control group and multiple treatment groups. The researchers evaluated various teratogenicity indices and conducted histopathological analysis. However, the sample size is not mentioned, which could affect the reliability of the results. Additionally, the abstract lacks information on the statistical analysis performed and the specific findings of the study. To improve the evidence, the researchers should provide details on the sample size, statistical analysis, and specific results obtained for each teratogenicity index. This would enhance the transparency and replicability of the study.

Introduction. Embelia schimperi Vatke (family Myrsinaceae) is a commonly consumed anthelminthic plant in Ethiopia. The plant has significant efficacy in treating intestinal worms. However, there are limited data about the safety/toxicity of the plant. Moreover, the teratogenic effect of the plant is not yet well studied despite significant number of Ethiopian mothers consuming herbal medication during their pregnancy. Purpose. This study aimed to evaluate the teratogenic effect of the hydroalcoholic extract of E. schimperi fruit on rat embryos and fetuses. Methods. Pregnant albino Wistar rats were treated with 80% hydroalcoholic fruit extract of E. schimperi at 250 mg/kg, 500 mg/kg, and 1000 mg/kg dosage, whilst the controls were pair-fed and ad libitum groups. Maternal food intake, maternal weight gain, number of implantations, number of prior resorptions, fetal viability, fetal weight, fetal and embryonic crown-ramp length, placental weight, placental gross morphology and histopathology of placental tissue, number of somites, embryonic system, gross/visceral morphological malformations, and ossification centers were evaluated as teratogenicity indices. Results. The crude extract of E. schimperi did not exhibit a significant difference in most developmental indices including the development of a circulatory system, nervous system, and musculoskeletal systems among treated animals and the controls. However, histopathological evaluation of placentas from the treatment groups showed that inflammatory reactions and calcifications compared to the pair-fed and ad libitum controls. Conclusion. Administration of the 80% hydroalcoholic extract of E. schimperi fruit during the period of organogenesis in rats did not show a significant toxic effect on embryonic and fetal developmental indices. However, it might affect the structural integrity of the placenta as it is evidenced by inflammatory reactions and calcifications of decidua basalis of rat placenta.

Fresh fruits of E. schimperi were collected from Debre Markos localities located 305 km northwest of the capital Addis Ababa, Ethiopia. The plant was identified and authenticated by a botanist at the Department of Plant Biology and Biodiversity Management, Addis Ababa University, where a voucher specimen (collection number ZA001) was deposited for future reference. Fruits of E. schimperi were dried at room temperature for two weeks at the herbarium of Traditional and Modern Medicine Research Directorate (TMMRD) of Ethiopian Public Health Institute (EPHI). The dried fruits were then ground using an electronic grinding mill. The powder was first defatted using n-hexane in a Soxhlet apparatus. This was followed by maceration of 100 g of the marc 1 L of 80% ethanol in a ratio of 1 : 10 (w/v). As a result, a yield of 12.8% dried crude extract was obtained. Nulliparous female albino Wistar rats weighing 220–250 g, which were not subjected to the previous experimental procedures, were used. The animals were maintained in a stainless-steel metallic cage at room temperature (22 ± 3°C) with a relative humidity of 50%–60% under a controlled alternating 12-hour light-dark cycle. Animals were acclimatized for 5 days prior to the experiment. During the period of adaptation, all the animals received food (pellet) and tap water ad libitum. Factors thought to bring fetal losses which were not treatment-related such as unnecessary handling of pregnant animals and stress from external factors like noise was minimized [12]. Mating was carried out by introducing a male albino Wistar rat of proven fertility into a cage containing two virgin female rats. Day-1 of gestation was determined the next morning after microscopic examination of vaginal smear to look for the presence of sperm cells. For those female rats with no sperm cells, a vaginal smear was repeated and examined the next morning. The male rat was maintained inside the same cage until confirmation of pregnancy [13, 14]. Pregnant rats were grouped randomly into five groups containing 10 pregnant rats in each group. The first three groups were treated with 250 mg/kg (Group I), 500 mg/kg (Group II), and 1000 mg/kg (Group III) of the crude extract suspended in distilled water, (1 ml/100 gm of body weight) [12] with free access to tap water and food. The animals in Group IV were categorized as a pair-fed control group and were supplied with the mean daily food intake of the previous three groups of animals with distilled water. The pair-fed control group was intended to evaluate if there would be a difference in the outcome variables due to food intake variation in the previous three groups. Group V animals were labeled as ad libitum control group taking food and water without restriction. The ad libitum group was designed to evaluate the effect of animal handling during administration of the crude extract. The doses were calculated based on previous studies [7, 10]. The extracts were administered through oral gavage. Experiments were carried out on 12 days old rat embryos and 20 days old fetuses. During both experiments, the treatment period was from day-6 through day-12 of gestation. The rationale behind selecting this period for treatment was due to the fact that this period represents a period of active embryogenesis and organogenesis. As a result, it was designated as the critical periods of rat development. Cage side clinical observation of animals was done once daily for possible signs of behavioral and physical changes throughout the experimental period. Coma, convulsions and tremors, eyes, feces consistency, fur and skin, mortality, mucous membrane, respiration, salivation, somatomotor activity, behavior pattern, and urination (colour) were the parameters during cage side evaluation as signs of toxicity. Cage side evaluation was done every 30 minutes for the first 4 hours after administration of the crude extract [15]. In order to avoid bias generally, we used double blinding manner during handling of lab animals, administration of the crude extract, and evaluation of the outcome variables. Each of the aforementioned activities were carried out anonymously by different individuals who had no clue about the grouping of animals and the given treatments. The purpose of this experiment was to evaluate the teratogenic effect of E. schimperi on 12 days old rat embryo. At the end of the treatment period (day-12 of gestation), the dams were anesthetized by injecting sodium pentobarbital 150 mg/kg intraperitoneally [16, 17]. Laparotomy was done to reveal the gravid uterine horns which was later dissected along the antimesometrial border to divulge the developing embryos. With the aid of GXM-XTL3T101 dissecting stereomicroscope and fine forceps, the membranes were removed along with the adjacent maternal tissue to reveal the embryo surrounded by a yolk sac. At this juncture, the yolk sac circulation became clearly visible and was evaluated thoroughly. The yolk sac was then removed to evaluate embryonic developmental indices like the embryonic nervous system, sensory organs, and musculoskeletal systems. These variables were examined according to the Brown and Fabro morphological scoring system [18] (Supplemental file) which was adopted for in vivo teratogenicity studies by Belete et al. [19] and Abebe et al. [16]. These experiments were carried out in 20 days old rat fetuses. The goal was to evaluate the potential toxicity of E. schimperi on fetomaternal outcomes and fetal developmental indices in near-term rat fetus. The weight of each pregnant animal was recorded on 1st, 6th, 12th, and 20th day of gestation. Food intake for every 24 hours was weighed the next morning at a constant time starting from day-1 of gestation up to day of sacrifice. Similarly, administration of the plant extract was done daily at a constant time [20]. On the day of sacrifice (day-20 of gestation), the dams were anesthetized by injecting sodium pentobarbital. Laparotomy was done to reveal the gravid uterus (Figure 1). Gravid uteruses were explanted immediately after the euthanasia and placed in a broad Petri dish. A careful incision was made along the antimesometrial border of the uterus guided by a dissecting microscope (GXM-XTL3T101 stereo microscope). The fetuses were revealed by removing the fetal membranes and detaching them from their respective placentas. After revealing the gravid uterus, the number of implantation sites and prior resorptions was counted and recorded. Alive/dead fetuses were counted after applying gentle pressure on them. Once the fetal membranes and other maternal tissues were removed, the fetuses were weighed using a calibrated digital balance (Mettler AE160). Crown-ramp length (CRL) was measured for every fetus. Placental weight was also recorded before histopathological tissue processing. 12 days old embryos from rats treated with 1000 mg/kg crude extract of E. schimperi. (a): Embryo enclosed by its yolk sac (YS) with visible vitelline vessels (VV), distinguishable head (HD), and tail (T) regions. (b): CNP (cranial neuropores/closed), FL (fore limb), HL (hind limb), ME (mesencephalon), PA (pharyngeal apparatus), RE (rhombencephalon), S (somite), and TE (telencephalon). Three placenta sample tissues were taken from each animal for gross examination and further histopathological analysis. Samples were initially fixed with 10% formaldehyde for 24 h. Then, tissue processing was carried out using an automatic tissue processor (Leica, TP 1020, Germany). The steps were arranged to start with dehydration by ascending gradient of alcohol concentration followed by clearing and impregnation by xylene and melted paraffin wax, respectively. The tissues were then embedded in paraffin wax and ready for sectioning. The thickness of the tissue to be sectioned by the microtome was adjusted to 5 μm for light microscopy. Finally, the tissues were stained by a hematoxylin and eosin technique [16, 21]. Later, the histological slides were examined by a senior pathologist under a light microscope for indices of functional as well as structural changes in the placenta [22, 23]. Fetuses were revealed by removing the fetal membranes and detaching them from their respective placentas. Afterward, each fetus was fully examined for the presence of gross structural malformations of craniofacial development, limb development, vertebral column, tail development, and external genitalia. After fetuses were fixed in Bouin’s solution (picric acid 75%, formalin 25%, and glacial acetic acid 5%), visceral/soft tissue evaluation was conducted by a free-hand razor blade sectioning technique based on a recommendation by Seegmiller et al. as a modified Willison’s technique [16]. The legs and tail were removed at the place of their attachment to the trunk before making a transverse cut between the jaws by a sharp blade. This will help to evaluate the palate for any cleft. Subsequently, coronal slices were made through the head to evaluate the presence of hydrocephalus, ventricular enlargement of the brain, and nasal septum defect [16]. Further transverse sections were made along the trunk to evaluate the possible existence of cardiovascular, respiratory, and abdominal defects. This experiment was designed to study the effect of E. schimperi on the process of bone formation on 20 days old rat fetus after staining the bones of the rat fetus. Three fetus/litter were sampled and further processed based on the Rigueur and Lyons method [24]. The initial step was euthanizing the fetus with pentobarbital followed by tissue permeabilization and skin removal facilitated by bathing for 30 sec in 60°C hot water. Afterwards, evisceration was done by making an abdominal incision. The eviscerated samples were immersed in a solution containing a fixative solution, 90% ethanol, for 24 h. The samples were then transferred to a container filled with 1% potassium hydroxide (KOH) for a purpose of soft tissue removal. Subsequently, the samples were stained for 24 h by a solution of alizarin red (0.005%) at 4°C to obtain an optimum level of skeletal staining. For those samples presumed to be over stained by alizarin red, Mall’s solution (79% distilled water, 20% glycerin, and 1% KOH) was used as a correction chemical. Finally, each sample was stored in an increasing concentration gradient of glycerol till examination. Hyoid bone, sternum, ribs, vertebrae, and bones, the upper and lower limbs were assessed against Nash and Persaud’s skeletal scoring chart [25]. Data were entered and analyzed using the Statistical Package for Social Science (SPSS) software version 24. The statistical results were exhibited in terms of the mean (μ) and the standard deviation (SD). One-way analysis of variance (ANOVA) with the post Hoc (Turkey) test and Chi-square test at P < 0.05 level of significance was employed to look over significant statistical differences among experimental groups. Results of placental histopathology were presented qualitatively based on predefined parameters [19, 26]. Ethical approval letter (Ref no. AAUMF03-008) was obtained from the Institutional Review Board (IRB) of the College of Health Sciences, Addis Ababa University with a protocol number 021/19/Anat in biddableness with OECD test guideline (TG-414/2018) [12]. Experimental animals were humanly handled based on the guidelines for ethical conduct in the care and use of nonhuman animals in research by American Psychological Association (APA) [27]. TMMRD/EPHI laboratory standards were also strictly followed in humanely disposing sacrificed rats.

Based on the provided information, it appears that the study titled “Teratogenic Evaluation of 80% Ethanol Extract of Embelia schimperi Vatke Fruits on Rat Embryo and Fetuses” is focused on evaluating the potential teratogenic effects of the hydroalcoholic extract of Embelia schimperi fruits on rat embryos and fetuses. The study aims to assess the safety/toxicity of the plant, particularly in relation to maternal consumption of herbal medication during pregnancy. The researchers conducted experiments on pregnant albino Wistar rats, administering different dosages of the extract and evaluating various developmental indices, including embryonic and fetal viability, weight, length, placental morphology, and histopathology.

In terms of innovations to improve access to maternal health, the study does not directly provide recommendations. However, it contributes to the field of maternal health by investigating the potential teratogenic effects of a commonly consumed anthelminthic plant in Ethiopia. This research can help inform healthcare providers and pregnant women about the safety of herbal medications during pregnancy, ultimately improving access to accurate information and promoting safer maternal health practices.
AI Innovations Description
The provided text appears to be a scientific research study on the teratogenic effect of Embelia schimperi Vatke fruits on rat embryos and fetuses. It does not directly relate to improving access to maternal health. To develop an innovation to improve access to maternal health, you may consider the following recommendations:

1. Strengthening healthcare infrastructure: Invest in improving healthcare facilities, including maternal health clinics, hospitals, and birthing centers. This can involve upgrading equipment, ensuring a sufficient number of skilled healthcare providers, and improving transportation systems for pregnant women in remote areas.

2. Enhancing community-based care: Implement community-based programs that provide prenatal care, education, and support to pregnant women. This can involve training community health workers to provide basic antenatal care, educate women about healthy practices during pregnancy, and identify high-risk pregnancies for referral to higher-level facilities.

3. Telemedicine and mobile health solutions: Utilize technology to provide remote access to maternal health services. This can include telemedicine consultations, mobile apps for tracking pregnancy progress, and SMS reminders for prenatal appointments and medication adherence.

4. Maternal health education and awareness: Develop comprehensive educational programs to raise awareness about maternal health issues, including the importance of antenatal care, nutrition, and birth preparedness. This can involve community workshops, radio programs, and educational materials targeting both women and their families.

5. Financial support and insurance coverage: Implement policies that provide financial support for maternal health services, such as subsidies for prenatal care, delivery, and postnatal care. Additionally, ensure that maternal health services are covered by health insurance schemes to reduce financial barriers to access.

6. Addressing cultural and social barriers: Identify and address cultural and social factors that may hinder access to maternal health services. This can involve community engagement, working with local leaders and influencers, and addressing gender inequalities that may affect women’s access to care.

7. Strengthening referral systems: Improve the coordination and communication between different levels of healthcare facilities to ensure timely and appropriate referrals for high-risk pregnancies and complications. This can involve training healthcare providers on referral protocols and establishing mechanisms for tracking referrals and outcomes.

It is important to note that these recommendations are general and may need to be adapted to the specific context and challenges faced in improving access to maternal health in a particular region or country.
AI Innovations Methodology
The provided text seems to be a scientific research article discussing the teratogenic effect of the hydroalcoholic extract of Embelia schimperi Vatke fruits on rat embryos and fetuses. It does not directly relate to innovations for improving access to maternal health. However, if you are looking for innovations in maternal health, I can provide some recommendations:

1. Telemedicine: Implementing telemedicine platforms can improve access to maternal health services, especially in remote or underserved areas. This allows pregnant women to consult with healthcare professionals remotely, reducing the need for travel and increasing access to prenatal care.

2. Mobile health (mHealth) applications: Developing mobile applications that provide information, reminders, and support for pregnant women can help improve access to maternal health resources. These apps can provide guidance on prenatal care, nutrition, and exercise, as well as send reminders for appointments and medication.

3. Community-based interventions: Implementing community-based interventions, such as training local health workers or traditional birth attendants, can improve access to maternal health services in areas with limited healthcare infrastructure. These interventions can provide basic prenatal care, education, and referrals for high-risk pregnancies.

4. Transportation solutions: Improving transportation infrastructure and providing transportation subsidies or services can help pregnant women reach healthcare facilities more easily. This can include initiatives like ambulance services, community transport, or partnerships with ride-sharing companies.

5. Health education and awareness campaigns: Conducting targeted health education and awareness campaigns can help improve access to maternal health services by providing information on the importance of prenatal care, family planning, and safe delivery practices. These campaigns can be conducted through various channels, including radio, television, social media, and community outreach programs.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include:

1. Baseline data collection: Gather data on the current state of maternal health access, including factors such as distance to healthcare facilities, availability of healthcare providers, and utilization rates of prenatal care.

2. Intervention implementation: Implement the recommended innovations, such as telemedicine platforms, mHealth applications, community-based interventions, transportation solutions, and health education campaigns.

3. Monitoring and evaluation: Continuously monitor the implementation of the interventions and collect data on key indicators, such as the number of telemedicine consultations, app usage rates, utilization of community-based services, transportation utilization, and changes in knowledge and behavior due to health education campaigns.

4. Data analysis: Analyze the collected data to assess the impact of the interventions on improving access to maternal health. This can include comparing utilization rates before and after the interventions, assessing changes in knowledge and behavior, and identifying any barriers or challenges faced during implementation.

5. Feedback and refinement: Use the findings from the data analysis to provide feedback and refine the interventions as needed. This iterative process can help optimize the innovations and further improve access to maternal health services.

It’s important to note that the methodology for simulating the impact of these recommendations may vary depending on the specific context and resources available.

Partilhar isto:
Facebook
Twitter
LinkedIn
WhatsApp
Email